Protein C Sapporo (protein C Glu 25 → Lys): A heterozygous missense mutation in the Gla domain provides new insight into the interaction between protein C and endothelial protein C receptor
暂无分享,去创建一个
H. Kaneko | H. Mizuno | T. Koike | T. Tarumi | I. Mizoguchi | T. Nakabayashi | M. Ieko | Y. Shikamoto | Kazuhiro Mizukami | S. Naitoh | Mika Takeda | T. Nakagawa
[1] S. Eichinger,et al. Deep vein thrombosis , 2005, The Lancet.
[2] B. Dahlbäck,et al. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation , 2004, The FEBS journal.
[3] F R Rosendaal,et al. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis , 2004, Journal of thrombosis and haemostasis : JTH.
[4] Justo Aznar,et al. Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk , 2004, Thrombosis and Haemostasis.
[5] N. Hamasaki,et al. Identification of simultaneous mutation of fibrinogen α chain and protein C genes in a Japanese kindred , 2003, British journal of haematology.
[6] K. Amano,et al. Two double heterozygous mutations in the F7 gene show different manifestations , 2002, British journal of haematology.
[7] K. Kottke-Marchant,et al. Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor. , 2002, Archives of pathology & laboratory medicine.
[8] N. Sakuragi,et al. Thromboprophylaxis with low molecular weight heparin in thrombophilia‐complicated pregnancy , 2002, The journal of obstetrics and gynaecology research.
[9] Zbigniew Dauter,et al. The Crystal Structure of the Endothelial Protein C Receptor and a Bound Phospholipid* , 2002, The Journal of Biological Chemistry.
[10] A. D’Angelo,et al. Plasma levels of endothelial protein C receptor respond to anticoagulant treatment. , 2002, Blood.
[11] G. Palù,et al. Abnormal Propeptide Processing Resulting in the Presence of Two Abnormal Species of Protein C in Plasma , 2001, Thrombosis and Haemostasis.
[12] C. Esmon,et al. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. , 2001, Blood.
[13] F. Rosendaal,et al. High levels of factor IX increase the risk of venous thrombosis. , 2000, Blood.
[14] C. Esmon,et al. The Endothelial Cell Protein C Receptor , 2000, Thrombosis and Haemostasis.
[15] F. Rosendaal,et al. High levels of coagulation factor XI as a risk factor for venous thrombosis. , 2000, The New England journal of medicine.
[16] C. Esmon,et al. Mechanisms by Which Soluble Endothelial Cell Protein C Receptor Modulates Protein C and Activated Protein C Function* , 2000, The Journal of Biological Chemistry.
[17] Mannucci,et al. Type II protein C deficiency: identification and molecular modelling of two natural mutants with low anticoagulant and normal amidolytic activity , 2000, British journal of haematology.
[18] B. Furie,et al. Vitamin K-Dependent Biosynthesis of γ-Carboxyglutamic Acid , 1999 .
[19] H. Blom,et al. Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysis , 1998, Thrombosis and Haemostasis.
[20] K. Fukudome,et al. Activation Mechanism of Anticoagulant Protein C in Large Blood Vessels Involving the Endothelial Cell Protein C Receptor , 1998, The Journal of experimental medicine.
[21] M. D'ambra,et al. Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin , 1997 .
[22] C. Esmon,et al. The Interaction between the Endothelial Cell Protein C Receptor and Protein C Is Dictated by the γ-Carboxyglutamic Acid Domain of Protein C* , 1997, The Journal of Biological Chemistry.
[23] P. Reitsma. Protein C Deficiency: from Gene Defects to Disease , 1997, Thrombosis and Haemostasis.
[24] W. Kisiel,et al. Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. , 1997, Biochemistry.
[25] D. Lane,et al. Gene Mutations in 21 Unrelated Cases of Phenotypic Heterozygous Protein C Deficiency and Thrombosis , 1996, Thrombosis and Haemostasis.
[26] P. Reitsma,et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.
[27] M. Aiach,et al. Molecular basis for protein C hereditary deficiency. , 1996, Haemostasis.
[28] C. Esmon,et al. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] F. Castellino,et al. Binding of calcium to individual gamma-carboxyglutamic acid residues of human protein C. , 1995, Biochemistry.
[30] J. Emmerich,et al. Influence of Six Mutations of the Protein C Gene on the Gla Domain Conformation and Calcium Affinity , 1994, Thrombosis and Haemostasis.
[31] Pieter H. Reitsma,et al. Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.
[32] J. Griffin,et al. Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three‐dimensional molecular modelling of mutations of the protease domain , 1994, Proteins.
[33] Tatsuya Hayashi,et al. A Compound Heterozygous Protein C Deficiency with a Single Nucleotide G Deletion Encoding Gly-381 and an Amino Acid Substitution of Lys for Gla-26 , 1993, Thrombosis and Haemostasis.
[34] M. Vidaud,et al. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis , 1993, British journal of haematology.
[35] F. Castellino,et al. Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. , 1992, Blood.
[36] R. Marlar,et al. Hereditary Dysfunctional Protein C Molecules (Type II): Assay Characterization and Proposed Classification , 1990, Thrombosis and Haemostasis.
[37] A A Connolly,et al. Deep vein thrombosis. , 1988, BMJ.
[38] Y. Sakata,et al. Conformation-specific monoclonal antibodies to the calcium-induced structure of protein C. , 1986, The Journal of biological chemistry.
[39] G. Crabtree,et al. Evolution and organization of the human protein C gene. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[40] E. Davie,et al. The nucleotide sequence of the gene for human protein C. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Katz,et al. INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANT , 1983, The Lancet.
[42] J. Griffin,et al. Deficiency of protein C in congenital thrombotic disease. , 1981, The Journal of clinical investigation.
[43] P. Simioni,et al. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. , 2006, Thrombosis research.
[44] J. Reny,et al. Hemostasis, Thrombosis, and Vascular Biology , 2022 .
[45] E. Persson. Ca 2+ Binding to Proteins Containing γ-Carboxyglutamic Acid Residues , 2002 .
[46] P. Reitsma,et al. High Plasma Concentration of Factor VIIIc Is a Major Risk Factor for Venous Thromboembolism , 2000, Thrombosis and Haemostasis.
[47] M. Aiach,et al. Thirty-three Novel Mutations in the Protein C Gene , 2000, Thrombosis and Haemostasis.
[48] H. Watzke,et al. Factor X Frankfurt I: molecular and functional characterization of a hereditary factor X deficiency (Gla+25 to Lys). , 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[49] B. Dahlbäck. The protein C anticoagulant system: inherited defects as basis for venous thrombosis. , 1995, Thrombosis research.
[50] N. Tsushima,et al. Three Missense Mutations in the Protein C Heavy Chain Causing Type I and Type II Protein C Deficiency , 1994, Thrombosis and Haemostasis.
[51] Triplett Da,et al. Clinical application of a functional assay for protein C. , 1987 .
[52] D. Triplett,et al. Clinical application of a functional assay for protein C. , 1987, Hematologic pathology.